Atrasentan Achieves Positive Topline Results in Phase 3 Trial for IgA Nephropathy
Atrasentan demonstrated superiority versus placebo for reduction in proteinuria through 36 weeks.
Source: hcplive.com
Immunoglobin A News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Immunoglobin A. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Immunoglobin A Today - Breaking & Trending Today